Less Chronic Pain After Lichtenstein Hernioplasty Using the Self-gripping Parietex Progrip Mesh
NCT ID: NCT01830452
Last Updated: 2013-04-12
Study Results
Results pending
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
Recruitment Status
UNKNOWN
Clinical Phase
PHASE4
Total Enrollment
400 participants
Study Classification
INTERVENTIONAL
Study Start Date
2010-09-30
Study Completion Date
2015-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Chronic pain after Lichtenstein hernioplasty is a common problem with an incidence of 11%. Many factors influence the onset and persistence of pain. Mesh characteristics and fixation have been pointed as important etiologic factors. This study compares two types of fixation for the same mesh. The mesh used is a lightweight parietex mesh. In the control group this mesh will be fixed with non absorbable sutures. In the study group sutures will not be needed because of self gripping microhooks on the surface of the mesh.
Methods: The HIPPO trial is a multicenter double blind randomized clinical trial. Patients will be randomly allocated to the sutured mesh or the self-gripping mesh. Hernia repair will be done according to Lichtenstein as described by Amid et all. Included will be all unilateral primary inguinal hernia in man patients aged 18 years or older not meeting the exclusion criteria. Patients will be followed for two years. The main endpoint is the amount of post-operative chronic pain evaluated by VAS scores. The existence of neuropathic pain will be evaluated by the Paindetect questionnaire (and a bedside variant of the QST). Secondary endpoints are recurrence rate, post-operative complications, costs, hospital stay, QOL, return to work and daily activities, genital and sexual problems. To demonstrate a difference in VAS score of 10 with α=0.05 and power 80% a sample size of 400 patients is calculated.
Discussion: Hypothesized is that the self gripping non-sutured mesh (Parietex Progrip) will cause less post-operative and chronic pain without enhancing the recurrence rate.
Methods: The HIPPO trial is a multicenter double blind randomized clinical trial. Patients will be randomly allocated to the sutured mesh or the self-gripping mesh. Hernia repair will be done according to Lichtenstein as described by Amid et all. Included will be all unilateral primary inguinal hernia in man patients aged 18 years or older not meeting the exclusion criteria. Patients will be followed for two years. The main endpoint is the amount of post-operative chronic pain evaluated by VAS scores. The existence of neuropathic pain will be evaluated by the Paindetect questionnaire (and a bedside variant of the QST). Secondary endpoints are recurrence rate, post-operative complications, costs, hospital stay, QOL, return to work and daily activities, genital and sexual problems. To demonstrate a difference in VAS score of 10 with α=0.05 and power 80% a sample size of 400 patients is calculated.
Discussion: Hypothesized is that the self gripping non-sutured mesh (Parietex Progrip) will cause less post-operative and chronic pain without enhancing the recurrence rate.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Parietex Progrip Study
NCT00827944
Hernia, Inguinal
COMPLETED
PHASE4
Chronic Pain After Inguinal Hernia Repair
NCT00820131
Inguinal Hernia
Chronic Pain
COMPLETED
PHASE4
Comparison of Three Meshes in Lichtenstein Hernia Repair
NCT01295437
Chronic Pain
Recurrences
COMPLETED
NA
The Outcome After Lichtenstein Operation vs. ProGrip Patch Repair of Inguinal Hernia
NCT01026935
Inguinal Hernia
Primary
Unilateral
COMPLETED
NA
Lichtenstein Patch or Prolene Hernia System (PHS) for Inguinal Hernia Repair
NCT01070693
Chronic Pain
COMPLETED
NA
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
INTRODUCTION
In 1984 Lichtenstein popularized routine use of a heavy weight polypropylene mesh fixed with non-absorbable sutures to create a tension-free hernioplasty. This technique became the gold standard in many clinics due to its low rate of recurrence and direct post-operative pain6. Focus has now shifted to the occurrence of chronic pain and neuralgia after Lichtenstein hernioplasty. Chronic post-operative pain has been defined as pain lasting more than 3 months after surgery. The surgical repair technique seems to be an important etiologic factor in this. This includes aspects like type of mesh used, manner of fixation of the prosthetic material and handling of the cutaneous nerves.
The aim of this study is to investigate differences in incidence of chronic post-operative pain between the two types of fixation for the same mesh. The mesh used is ligthweight and made of polyester. The mesh will be fixated by either non-adsorbable sutures, according to Lichtenstein, or by small microhooks on the lower surface of the mesh (Parietex Progrip Mesh, Covidien).
Rationale for the Parietex Progrip Mesh
To reduce post-operative chronic pain it is thought being important to use low weight large pore size oligofilament meshes fixed with a minimal use of devices or no devices at all. This both to minimize compression/entrapment neuropathy and inflammation. The Parietex Progrip mesh biocompatibility is enhanced using low-weight monofilament isoelastic polyester with large pores. The hydrophilic characteristics of polyester are known to cause less shrinkage and fibrotic tissue formation than the more standard polypropylene.
The need for fixating devices is bypassed by small absorbable microhooks (polyactid acid, PLA) on the surface of the Progrip Mesh. Mesh fixation by the micro hooks to the underlying groin tissue is achieved instantly after exerting light pressure on the mesh. The fixation by the micro-hooks is achieved for the fully mesh area in contrast to other meshes in which only the margins of the mesh are sutured. Therefore it is likely that there is less risk of movement or displacement of the hernial sac under the mesh. The PLA micro hooks will be completely resorbed after 15 months. Then the mesh is firmly connected to the groin bed by tissue ingrow. After resorption of the PLA only the low-weight (38 g/m2) monofilament polyester (PP) will be left in situ.
The mesh has an oval shape with a self-gripping flap to be placed around the spermatic cord at the internal ring.
A recently performed pilotstudy comparing the Parietene (made of polypropylene) Progrip mesh to the standard mesh in the clinic, a heavy weight sutured polypropylene mesh, revealed a significant lower incidence of chronic pain in the Parietene Progrip group (P=0.012). Recurrence rates were not different. Operation time was significantly shorter for the Parietene Progrip Mesh group.(p=0.002).
METHODS
Study objective
The aim is to compare two types of fixation for the same mesh in inguinal hernia repair as described by Lichtenstein; a lightweight polyester mesh which has to be sutured will be compared to a lightweight polyester mesh with self-gripping properties not needing any fixating devices. It is already proved that lightweight meshes reduce the amount of foreign body reaction resulting in less chronic pain. The self fixing properties are believed to enhance this effect by minimizing entrapment of muscle and nerve fibres.
Primary endpoint
The primary endpoint is the amount of post-operative chronic groin pain. This will be evaluated using visual analogue scale (VAS) and Mc Gill Pain questionnaire. In a subgroup of 50 patients the amount of pain en pain threshold before and after the hernioplasty will be objectified by quantitative sensory testing (QST).
Secondary endpoints
Secondary objectives are recurrence rate, per operative and post-operative complications, operating time, duration of hospital stay, costs, return to work and daily activities, QOL, genital and sexual problems.
Study design
The HIPPO trial is a multicenter double blind randomized clinical trial. Preoperative randomization will be done using an official randomisation program. All included study subjects will be registered in this program. On the day of surgery the operation assistant will login in the randomisation program and start the randomisation procedure for the patient to be operated. The outcome will appear in a couple of seconds and will be stored in a secured database. Which type of mesh is to be used will be known for the surgeon not earlier than preparation of the inguinal floor is finished and the surgeon is ready to place a mesh. In the case the patient is not sleeping during the operation it is possible that he notice whether the mesh is fixed with sutures or not. To be sure this will not happen patients who do not want to sleep will get an ear-radio and eye mask.
The investigator assessing the outcome on the outpatient department will not be informed about the outcome of randomisation. Besides this, operation reports will not mention which type of mesh has been used. The randomisation code can be broken by the owner of the randomisation program, but only in case of a medical urgency and in order of a medical doctor.
Patients
Patients will be included on the outpatient clinic of the department of General Surgery of the departing hospitals. This will be done by surgeons and supervised residents. After inclusion patients have to sign informant consent and fill in a couple of questionnaires: SF36 (Short Form, measuring quality of life), McGill pain questionnaire, VAS, Dutch and Inguinal hernia questionnaire (to be validated). Follow-up will be at 2weeks, 3 months, 12 months and 24 months post-operatively. For each follow-up visit patients have to complete the same questionnaires at home. Besides this they will be examined on the clinic for the detection of complications (eg recurrence, wound problems) and to perform sensibility tests.
Subjects can leave the study at any time for any reason if they wish to do so without any consequences. The investigator can decide to withdraw a subject from the study for urgent medical reasons
Inclusion criteria
* Primary unilateral inguinal hernia
* Capacitated male person
* Age ≥ 18 years
Exclusion criteria
* Concurrent femoral hernia
* Incarcerated or strangulated inguinal hernia
* ASA 4 or ASA 5
* Impaired adequate follow up
* Participation in another trial
Sample size calculation
The primary endpoint is the VAS score. A difference of 10 in post-operative Visual Analogue Scale score between the intervention and control group is considered to be the minimum relevant clinical difference. According to the power analyse, 169 patients per treatment group are needed to achieve this with a power of 80% with an alpha of 5%. The calculation was made with a two-sided test for the VAS pain score at 3 months. Based on the pilotstudie the standard deviation was set at 20.
Statistical comparison will be made using the Wilcoxon test for continuous data and the Pearson chi squared test for ordinal data. The Wilcoxon test will also be used to analyse the SF36 scores and nominal operative parameters. P\<0.05 will be considered statistically significant.
Ethics, informed consent
The study will be conducted according to the principles of the Declaration of Helsinki 59th amended by the World Medical Association General Assembly, Seoul, October and in accordance with the Medical Research Involving Human Subjects Act (WMO). The protocol has been approved by the independent ethics committee of the participating hospitals and the Leiden University Medical Centre. All patients who are asked to co-operate in the study are verbally informed and by patient information letter. The handling of personal date will comply with the Dutch Personal Data Protection Act. Data will be saved for maximal 5 year after public disclosure of the research results.
Diagnosis
An inguinal hernia is defined as a protrusion of the contents of the abdominal cavity or preperitoneal fat through a hernia defect in the inguinal area which can be congenital or acquired. This situation can give rise to complaints such as discomfort and pain. Conform the recommendation of the EHS (European Hernia Society, last version 2009) the diagnosis of inguinal hernia will be established by means of physical examination. Groin diagnostic investigations will be performed only in patients with obscure pain and/or swelling. The inguinal hernia will be classified using the EHS classification.
Anesthesia
Pre-operatively all patients will be seen by the anaesthetist on the pre-operative outpatient clinic. The type of anaesthesia (general or spinal with short acting agents) will be decided by the anaesthetist taking into account the preference of the patient. There are standard protocols for the general or spinal anaesthesia.
Surgical technique
The inguinal hernia will be corrected according to Lichtenstein, as described by Amid et all. This is the treatment recommended for primary unilateral inguinal hernia by the Dutch Society of Surgeons and the European Hernia Society. In half of the study population a lightweigth polyester mesh (Parietex Mesh, Covidien) will be used, fixed with non-absorbable sutures as described by Amid. In the other half a lightweigth self gripping polyester mesh (Parietex Progrip Mesh, Covidien) will be used. This mesh will be placed the same way as the sutured mesh e.g. tension free over the posterior wall of the inguinal canal 1cm overlapping the pubic bone and inguinal ligament. The self gripping flap will be closed loosely around the spermatic cord. Fixation will be achieved by applying light pressure on the mesh. No fixating suture(s) are necessary. The parietex progrip mesh is preshaped, but corrections in size are allowed to be made.
Conform the recommendations of the EHS the inguinal nerves at risk (ilio-inguinal, iliohypogastric and genitofemoral nerve) will be tried to be identified, because this may reduce the risk of nerve damage and post-operative groin pain. In principle the nerves will be preserved, but in case of damage or interference with the mesh they will be resected.
It is recommended that, in the case of large hernia sac, transection of the hernia sac is performed and the distal hernia sac is left undisturbed, so as to prevent ischaemic orchitis. If necessary, a large direct hernia will be sutured tension-free with continuous soluble sutures until a flat posterior wall has been created with a normal internal ring. Operations will be performed by surgeons or supervised residents.
Post-operative pain control and recovery
After hernia repair the wound will be locally infiltrated with analgesics to provide extra pain control and limit the use of analgesics. The amount of painkillers given to the patients will depend on their VAS score. This is a standardised regimen based on current practice. Post-operative painkillers include paracetamol 1 gram four times daily and diclofenac 50 gram three times daily. When this is not satisfying tramadol 50mg 3 times daily can be given. According to the EHS there are no limitations placed on patients following inguinal hernia operation and patients are, therefore, free to resume activities. They are only advised to limit heavy weight lifting for 2-3 weeks after surgery.
CONCLUSION
The HIPPO is a double blind randomised controlled trial that aims to show a reduction in chronic pain after anterior inguinal hernia repair with placement of a self gripping Parietex Progrip Mesh compared to the same mesh but sutured according to Lichtenstein. Hypothetically the Parietex Progrip Mesh reduces chronic pain compared to Lichtenstein because of less harm to underlying nerve and muscle fibers.
Competing interests The authors declare that they have no competing interests. Objective analyses will be performed on the TULIP data. There will be no violating of this study protocol.
In 1984 Lichtenstein popularized routine use of a heavy weight polypropylene mesh fixed with non-absorbable sutures to create a tension-free hernioplasty. This technique became the gold standard in many clinics due to its low rate of recurrence and direct post-operative pain6. Focus has now shifted to the occurrence of chronic pain and neuralgia after Lichtenstein hernioplasty. Chronic post-operative pain has been defined as pain lasting more than 3 months after surgery. The surgical repair technique seems to be an important etiologic factor in this. This includes aspects like type of mesh used, manner of fixation of the prosthetic material and handling of the cutaneous nerves.
The aim of this study is to investigate differences in incidence of chronic post-operative pain between the two types of fixation for the same mesh. The mesh used is ligthweight and made of polyester. The mesh will be fixated by either non-adsorbable sutures, according to Lichtenstein, or by small microhooks on the lower surface of the mesh (Parietex Progrip Mesh, Covidien).
Rationale for the Parietex Progrip Mesh
To reduce post-operative chronic pain it is thought being important to use low weight large pore size oligofilament meshes fixed with a minimal use of devices or no devices at all. This both to minimize compression/entrapment neuropathy and inflammation. The Parietex Progrip mesh biocompatibility is enhanced using low-weight monofilament isoelastic polyester with large pores. The hydrophilic characteristics of polyester are known to cause less shrinkage and fibrotic tissue formation than the more standard polypropylene.
The need for fixating devices is bypassed by small absorbable microhooks (polyactid acid, PLA) on the surface of the Progrip Mesh. Mesh fixation by the micro hooks to the underlying groin tissue is achieved instantly after exerting light pressure on the mesh. The fixation by the micro-hooks is achieved for the fully mesh area in contrast to other meshes in which only the margins of the mesh are sutured. Therefore it is likely that there is less risk of movement or displacement of the hernial sac under the mesh. The PLA micro hooks will be completely resorbed after 15 months. Then the mesh is firmly connected to the groin bed by tissue ingrow. After resorption of the PLA only the low-weight (38 g/m2) monofilament polyester (PP) will be left in situ.
The mesh has an oval shape with a self-gripping flap to be placed around the spermatic cord at the internal ring.
A recently performed pilotstudy comparing the Parietene (made of polypropylene) Progrip mesh to the standard mesh in the clinic, a heavy weight sutured polypropylene mesh, revealed a significant lower incidence of chronic pain in the Parietene Progrip group (P=0.012). Recurrence rates were not different. Operation time was significantly shorter for the Parietene Progrip Mesh group.(p=0.002).
METHODS
Study objective
The aim is to compare two types of fixation for the same mesh in inguinal hernia repair as described by Lichtenstein; a lightweight polyester mesh which has to be sutured will be compared to a lightweight polyester mesh with self-gripping properties not needing any fixating devices. It is already proved that lightweight meshes reduce the amount of foreign body reaction resulting in less chronic pain. The self fixing properties are believed to enhance this effect by minimizing entrapment of muscle and nerve fibres.
Primary endpoint
The primary endpoint is the amount of post-operative chronic groin pain. This will be evaluated using visual analogue scale (VAS) and Mc Gill Pain questionnaire. In a subgroup of 50 patients the amount of pain en pain threshold before and after the hernioplasty will be objectified by quantitative sensory testing (QST).
Secondary endpoints
Secondary objectives are recurrence rate, per operative and post-operative complications, operating time, duration of hospital stay, costs, return to work and daily activities, QOL, genital and sexual problems.
Study design
The HIPPO trial is a multicenter double blind randomized clinical trial. Preoperative randomization will be done using an official randomisation program. All included study subjects will be registered in this program. On the day of surgery the operation assistant will login in the randomisation program and start the randomisation procedure for the patient to be operated. The outcome will appear in a couple of seconds and will be stored in a secured database. Which type of mesh is to be used will be known for the surgeon not earlier than preparation of the inguinal floor is finished and the surgeon is ready to place a mesh. In the case the patient is not sleeping during the operation it is possible that he notice whether the mesh is fixed with sutures or not. To be sure this will not happen patients who do not want to sleep will get an ear-radio and eye mask.
The investigator assessing the outcome on the outpatient department will not be informed about the outcome of randomisation. Besides this, operation reports will not mention which type of mesh has been used. The randomisation code can be broken by the owner of the randomisation program, but only in case of a medical urgency and in order of a medical doctor.
Patients
Patients will be included on the outpatient clinic of the department of General Surgery of the departing hospitals. This will be done by surgeons and supervised residents. After inclusion patients have to sign informant consent and fill in a couple of questionnaires: SF36 (Short Form, measuring quality of life), McGill pain questionnaire, VAS, Dutch and Inguinal hernia questionnaire (to be validated). Follow-up will be at 2weeks, 3 months, 12 months and 24 months post-operatively. For each follow-up visit patients have to complete the same questionnaires at home. Besides this they will be examined on the clinic for the detection of complications (eg recurrence, wound problems) and to perform sensibility tests.
Subjects can leave the study at any time for any reason if they wish to do so without any consequences. The investigator can decide to withdraw a subject from the study for urgent medical reasons
Inclusion criteria
* Primary unilateral inguinal hernia
* Capacitated male person
* Age ≥ 18 years
Exclusion criteria
* Concurrent femoral hernia
* Incarcerated or strangulated inguinal hernia
* ASA 4 or ASA 5
* Impaired adequate follow up
* Participation in another trial
Sample size calculation
The primary endpoint is the VAS score. A difference of 10 in post-operative Visual Analogue Scale score between the intervention and control group is considered to be the minimum relevant clinical difference. According to the power analyse, 169 patients per treatment group are needed to achieve this with a power of 80% with an alpha of 5%. The calculation was made with a two-sided test for the VAS pain score at 3 months. Based on the pilotstudie the standard deviation was set at 20.
Statistical comparison will be made using the Wilcoxon test for continuous data and the Pearson chi squared test for ordinal data. The Wilcoxon test will also be used to analyse the SF36 scores and nominal operative parameters. P\<0.05 will be considered statistically significant.
Ethics, informed consent
The study will be conducted according to the principles of the Declaration of Helsinki 59th amended by the World Medical Association General Assembly, Seoul, October and in accordance with the Medical Research Involving Human Subjects Act (WMO). The protocol has been approved by the independent ethics committee of the participating hospitals and the Leiden University Medical Centre. All patients who are asked to co-operate in the study are verbally informed and by patient information letter. The handling of personal date will comply with the Dutch Personal Data Protection Act. Data will be saved for maximal 5 year after public disclosure of the research results.
Diagnosis
An inguinal hernia is defined as a protrusion of the contents of the abdominal cavity or preperitoneal fat through a hernia defect in the inguinal area which can be congenital or acquired. This situation can give rise to complaints such as discomfort and pain. Conform the recommendation of the EHS (European Hernia Society, last version 2009) the diagnosis of inguinal hernia will be established by means of physical examination. Groin diagnostic investigations will be performed only in patients with obscure pain and/or swelling. The inguinal hernia will be classified using the EHS classification.
Anesthesia
Pre-operatively all patients will be seen by the anaesthetist on the pre-operative outpatient clinic. The type of anaesthesia (general or spinal with short acting agents) will be decided by the anaesthetist taking into account the preference of the patient. There are standard protocols for the general or spinal anaesthesia.
Surgical technique
The inguinal hernia will be corrected according to Lichtenstein, as described by Amid et all. This is the treatment recommended for primary unilateral inguinal hernia by the Dutch Society of Surgeons and the European Hernia Society. In half of the study population a lightweigth polyester mesh (Parietex Mesh, Covidien) will be used, fixed with non-absorbable sutures as described by Amid. In the other half a lightweigth self gripping polyester mesh (Parietex Progrip Mesh, Covidien) will be used. This mesh will be placed the same way as the sutured mesh e.g. tension free over the posterior wall of the inguinal canal 1cm overlapping the pubic bone and inguinal ligament. The self gripping flap will be closed loosely around the spermatic cord. Fixation will be achieved by applying light pressure on the mesh. No fixating suture(s) are necessary. The parietex progrip mesh is preshaped, but corrections in size are allowed to be made.
Conform the recommendations of the EHS the inguinal nerves at risk (ilio-inguinal, iliohypogastric and genitofemoral nerve) will be tried to be identified, because this may reduce the risk of nerve damage and post-operative groin pain. In principle the nerves will be preserved, but in case of damage or interference with the mesh they will be resected.
It is recommended that, in the case of large hernia sac, transection of the hernia sac is performed and the distal hernia sac is left undisturbed, so as to prevent ischaemic orchitis. If necessary, a large direct hernia will be sutured tension-free with continuous soluble sutures until a flat posterior wall has been created with a normal internal ring. Operations will be performed by surgeons or supervised residents.
Post-operative pain control and recovery
After hernia repair the wound will be locally infiltrated with analgesics to provide extra pain control and limit the use of analgesics. The amount of painkillers given to the patients will depend on their VAS score. This is a standardised regimen based on current practice. Post-operative painkillers include paracetamol 1 gram four times daily and diclofenac 50 gram three times daily. When this is not satisfying tramadol 50mg 3 times daily can be given. According to the EHS there are no limitations placed on patients following inguinal hernia operation and patients are, therefore, free to resume activities. They are only advised to limit heavy weight lifting for 2-3 weeks after surgery.
CONCLUSION
The HIPPO is a double blind randomised controlled trial that aims to show a reduction in chronic pain after anterior inguinal hernia repair with placement of a self gripping Parietex Progrip Mesh compared to the same mesh but sutured according to Lichtenstein. Hypothetically the Parietex Progrip Mesh reduces chronic pain compared to Lichtenstein because of less harm to underlying nerve and muscle fibers.
Competing interests The authors declare that they have no competing interests. Objective analyses will be performed on the TULIP data. There will be no violating of this study protocol.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Hernia, Inguinal
Unilateral Inguinal Hernia
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
Allocation Method
RANDOMIZED
Intervention Model
FACTORIAL
Primary Study Purpose
TREATMENT
Blinding Strategy
TRIPLE
Participants
Investigators
Outcome Assessors
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Parietex Progrip mesh
Ventral hernioplasty using a (self gripping / self adhering / self fixating) Progrip mesh not needing fixation devices
Group Type
EXPERIMENTAL
Self-fixating Parietex Progrip Mesh
Intervention Type
PROCEDURE
Lichtenstein hernioplasty using a self fixating Parietex Progrip mesh not needing any fixating devices
Parietex Mesh
Ventral hernioplasty using a polyester mesh fixed with non absorbable sutures as described by Lichtenstein/Amid
Group Type
ACTIVE_COMPARATOR
Self-fixating Parietex Progrip Mesh
Intervention Type
PROCEDURE
Lichtenstein hernioplasty using a self fixating Parietex Progrip mesh not needing any fixating devices
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Self-fixating Parietex Progrip Mesh
Lichtenstein hernioplasty using a self fixating Parietex Progrip mesh not needing any fixating devices
Intervention Type
PROCEDURE
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Open hernioplasty
Inguinal hernioplasty
Anterior hernioplasty
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Primary unilateral inguinal hernia
* Capacitated male person
* Age ≥ 18 years
* Capacitated male person
* Age ≥ 18 years
Exclusion Criteria
* Concurrent femoral hernia
* Incarcerated or strangulated inguinal hernia
* ASA 4 or ASA 5
* Impaired adequate follow up
* Participation in another trial
* Incarcerated or strangulated inguinal hernia
* ASA 4 or ASA 5
* Impaired adequate follow up
* Participation in another trial
Minimum Eligible Age
18 Years
Eligible Sex
MALE
Accepts Healthy Volunteers
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Erasmus Medical Center
OTHER
Sponsor Role
collaborator
Groene Hart Ziekenhuis
OTHER
Sponsor Role
lead
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Marijke Molegraaf
MD
Responsibility Role
PRINCIPAL_INVESTIGATOR
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Johan F Lange, Prof
Role: STUDY_DIRECTOR
Erasmus Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Groene Hart Ziekenhuis
Gouda, , Netherlands
Site Status
RECRUITING
Sint Franciscus Gasthuis
Rotterdam, , Netherlands
Site Status
RECRUITING
Countries
Review the countries where the study has at least one active or historical site.
Netherlands
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Molegraaf MJ, Grotenhuis B, Torensma B, de Ridder V, Lange JF, Swank DJ. The HIPPO Trial, a Randomized Double-blind Trial Comparing Self-gripping Parietex Progrip Mesh and Sutured Parietex Mesh in Lichtenstein Hernioplasty: A Long-term Follow-up Study. Ann Surg. 2017 Dec;266(6):939-945. doi: 10.1097/SLA.0000000000002169.
Reference Type
DERIVED
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NL27506.058.09
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.
Comparison Between Elliptical Domed Mesh Technique and Lichtenstein Technique in Inguinal Hernia
NCT01348477
UNKNOWN
NA
Mesh Fixation in Lichtenstein Hernioplasty
NCT01592942
UNKNOWN
NA
ProGrip Mesh Repair vs Lichtenstein Operation
NCT02748629
COMPLETED
NA
Polypropylene Mesh Versus Polytetrafluoroethylene (PTFE) Mesh in Inguinal Hernia Repair
NCT01141335
COMPLETED
PHASE4
RCT Comparing Lightweight vs. Heavyweight Meshes in Incisional Hernia Repair
NCT04961346
COMPLETED
NA
Progrip Ventral Study for Sublay Repair
NCT01622127
COMPLETED
Chronic Postoperative Pain After the Lichtenstein Groin Hernioplasty
NCT04839848
COMPLETED
Comparing Pain After Laparoscopic Hernia Repair Using Two Different Types of Mesh Fixation
NCT02467140
UNKNOWN
NA
Study Comparing Total Extraperitoneal Patch "TEP" Versus Lichtenstein According Chronic Pain
NCT00803985
COMPLETED
NA
Comparative Study on the Post-operative Pain and Other Outcomes of Mesh Fixation With Prolene vs Vicryl vs Skin Staples in Lichtenstein Inguinal Hernia Repair.
NCT07210424
NOT_YET_RECRUITING
Comparison of Self-Fixating vs Non-Fixating Hernia Mesh
NCT02062775
COMPLETED
NA
Comparative Study of Inguinodynia After Inguinal Hernia Repair
NCT03678272
COMPLETED
NA
Predisposing Factors for Chronic Postherniotomy Pain
NCT00649142
COMPLETED
NA
Tacking Mesh Versus Self-fixating Mesh for Inguinal Hernia Repair
NCT03247985
COMPLETED
NA
Prospective Trial Comparing Two Different Polypropylene Meshes for Inguinal Hernias
NCT01825187
COMPLETED
NA
Prospective Randomized Trial Comparing Lichtenstein's Repair of Inguinal Hernia With Polypropylene Mesh Versus Surgisis
NCT00614419
COMPLETED
PHASE4
Study of a New Laparoscopic Technique for Parastomal Hernia Repair With Mesh
NCT00138957
WITHDRAWN
NA
Comparative Study on Self-adhesive Mesh for Open Inguinal Hernia Repair
NCT00960011
COMPLETED
NA
TAPP Inguinal Hernia Repair With Self-fixating Parietex™ ProGrip™ Mesh
NCT01481376
COMPLETED
Study Evaluating the Impact of Mesh Pore Size on Chronic Pain After Lichtenstein Hernioplasty
NCT02500056
COMPLETED
NA
Comparison of Patient Perceived Pain and Satisfaction Between Lightweight and Heavyweight Mesh for Laparoscopic Inguinal Hernia Repair
NCT01638221
UNKNOWN
Glubran Mesh Fixation in Lichtenstein Hernioplasty
NCT00659542
COMPLETED
PHASE2
Long-term Follow-up of Lichtenstein's Operation Versus Mesh Plug Repair
NCT01637818
COMPLETED
NA